Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

Else Marie Agger, Ida Rosenkrands, Jon Hansen, +10

PLoS ONE

Ultrasound research scanner for real-time synthetic aperture data acquisition

Jørgen Arendt Jensen, Olle Holm, L.J. Jerisen, +10

IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control

Recruitment of BAD by the Chlamydia trachomatis Vacuole Correlates with Host-Cell Survival

Philippe Verbeke, Lynn Welter-Stahl, Songmin Ying, +4

PLoS Pathogens

Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant

Karen Smith Korsholm, Jon Hansen, Kasper K. Karlsen, +6

Vaccine

Cd8+ T-cell ResponsesSubunit AntigensT-regulatory CellImmunologyAntigen Processing +7

Experimental ultrasound system for real-time synthetic imaging

Jørgen Arendt Jensen, Olle Holm, L.J. Jensen, +5

Medical UltrasoundEngineeringMedical TechnologyAdvanced ImagingBiomedical Engineering +16

Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

Jürgen Brem, Tharindi Panduwawala, Jon Hansen, +57

Nature Chemistry

Molecular PharmacologyMedicinal ChemistryAntimicrobial Drug DiscoveryMedicineNatural Sciences +9

Liposome Delivery of<i>Chlamydia muridarum</i>Major Outer Membrane Protein Primes a Th1 Response That Protects against Genital Chlamydial Infection in a Mouse Model1

Jon Hansen, Klaus T. Jensen, Frank Follmann, +3

The Journal of Infectious Diseases

CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice

Jon Hansen, Thomas Lindenstrøm, Julie Lindberg-Levin, +3

Cancer Immunology Immunotherapy

Cancer ResearchCationic LiposomesMedicineTumor BurdenImmunology +11

Topical niclosamide (ATx201) reduces <i>Staphylococcus aureus</i> colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial

Anne Weiss, Emilie Delavenne, Carina Matias, +34

Clinical and Translational Medicine

Model‐Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin

Tomás Sou, Jon Hansen, Edgars Liepinsh, +13

Clinical Pharmacology & Therapeutics

Antimicrobial ChemotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingDrug ResistancePharmacological Study +18